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Summary and Implications 
Commercial pyrethroid pour-ons are commonly applied 
in cow-calf operations to eliminate the potential for insect 
borne diseases and to improve productivity. However, 
recent literature has focused on potential negative 
reproductive effects in the bull after exposure to pyrethroids. 
While the female bovine has been primarily neglected from 
the debated pyrethroid concern on reproduction, literature in 
mice and rats have reported potential endocrine disruption 
of sex steroids resulting from pyrethroid exposure, with 
potential detrimental effects on female fertility.  The 
objective was to study the effects of a commercial 
pyrethroid-based pour-on product, permethrin, on 
reproductive performance in superovulated beef heifers by 
assessing steroid biosynthesis and embryo quality. It was 
hypothesized that exposure to pyrethroid pour-on at label 
dose would cause minimal effects on embryo 
quantity/quality and steroidogenesis in the female bovine. 
Results from this study revealed pyrethroid-treated heifers 
had a tendency for reduced progesterone, but embryo 
quantity and quality were not affected compared to controls.  
Introduction 
 Pyrethroid exposure has been implicated to disrupt 
important reproductive and endocrine functions. In addition, 
endocrine disruption is speculated to influence the 
hypothalamic-pituitary-gonadal axis and impair the 
necessary feedback mechanisms of hormones that provide 
the required stability to regulate normal reproductive 
physiology. Previous observational findings have claimed 
that bulls exposed to pyrethroids have decreased 
reproductive function. However, recent literature has refuted 
that claim. 
It is important to note that endocrine disruption is not 
believed to be sex specific, and thus likely to potentially 
affect female reproductive physiology by inhibiting normal 
reproductive functions. Previous research has indicated 
pyrethroids may inhibit progesterone concentrations by 
down-regulating expression of cP450scc and StAR. In 
addition, literature using mice and rats as the model have 
shown delay in puberty in females exposed to pyrethroid 
substances.  However, there are postulated thoughts that 
endocrine disruption chemicals (EDC) could also stimulate 
changes in the reproductive tract that impede sperm 
migration, sperm adhesion, capacitation, zona binding, 
acrosomal reaction, or penetration into the oocyte or the 
competency for maturation of a developing  embryos. Pre-
implantation losses with reduction of implantation sites has 
been reported with rats receiving orally administered 
pyrethroids in early gestation, which could imply that 
exposure to pyrethroids could develop a hostile environment 
or cause abnormal synchronization of embryo development 
or implantation.  
The overall reproductive effects of pyrethroid exposure 
to female cattle have not been studied in as much detail as 
the bull. The objective of this study was to elucidate the 
effects of a commercial pyrethroid-based pour-on product, 
permethrin, on reproductive performance in superovulated 
beef heifers by assessing steroid synthesis and embryo 
quality. It was hypothesized that exposure to pyrethroid 
pour-on at label dose would cause minimal effects on 
reproductive parameters in the female bovine.  
 
Materials and Methods 
Non-pregnant, purebred Simmental and crossbred 
yearling beef heifers (n=10; 418 ± 33 kg; 5.5 ± 0.2 BCS) 
were used in this study. Prior to treatment, all heifers were 
subjected to a trans-rectal reproductive ultrasound 
examination to confirm normal ovarian activity and 
cyclicity. At that time, initial body weight (BW) and body 
conditioning scores (BCS) were recorded and heifers were 
blocked by breed and BW. Heifers were assigned to either 
1) a saline control (CON; n=5) or 2) a permethrin pour-on 
treatment group (PYR; n=5).  The PYR heifers received a 
one-time label dose of permethrin (5% permethrin and 5% 
piperonyl butoxide, 3 mL per 45kg BW up to a maximum of 
30 mL) for lice and fly control.  The CON group received 
the same volume of saline. Both products were administered 
on the topline of the heifers. Treatment groups were housed 
one pen per treatment to avoid cross-contamination. All 
heifers received the same environmental and nutritional 
treatment before and after treatment. 
Treatments were initiated at the start of superovulation 
protocol. All heifers were subjected to superstimulation by 
utilizing a timed, 17-d, CIDR-based protocol with GnRH 
and PGF2α with decreasing dosages of FSH administered 
twice daily for 4 days (Experimental Design, Figure 1). 
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Heifers were artificially inseminated (AI) twice either at 
onset of estrus or by the timed-AI and additionally 12 hrs 
later by same technician with one unit of frozen semen, at 
each insemination, from a single bull collection. A dose of 
GnRH was given at time of second breeding. At 6.5 d post-
timed-AI, trans-rectal ultrasound was performed to assess 
corpus luteum (CL) number, number of unovulated follicles, 
and total ovarian structures (CL and unovulated follicles). 
Immediately following ultrasound, non-surgical embryo 
recovery was performed. All recovered embryos were 
evaluated according to International Embryo Transfer 
Society (IETA) standards by blinded American Embryo 
Transfer Association (AETA) certified personnel.  
To determine potential long-term effects of permethrin 
on embryo quality and steroid biosynthesis, an identical 
superstimulation protocol was initiated again 34 d post-
treatment with embryo recovery performed 51 d post-
treatment. On the second flush, one heifer had abnormal 
oviduct pathology and embryo data was not used.  
Blood was collected via coccygeal tail vein at insertion 
of CIDR™, standing estrus, and day of embryo recovery to 
evaluate baseline (basal) estradiol-17β, peak estradiol-17β, 
and progesterone (P4) concentrations, respectively. Blood 
was centrifuged and the plasma was utilized for the 
hormone analysis using radioimmunoassay (RIA).  
 
Figure 1.  Experimental Design  
Day Time Administrations Ultrasound/ 
Blood Collection 
-33 am …….. U/S, BW + BCS 
0 am CIDR™-insertion + 625 mcg PGF2α 
+ Ultraboss® or Saline Treatment 
Basal Estradiol 
4 am 150 mcg GnRH ….. 
5 pm 40 mg FSH ….. 
6 am/pm 40 mg F SH, 30 mg FSH ….. 
7 am/pm 30 mg FSH, 30 mg FSH ….. 
8 am 30 mg FSH ….. 
8 pm 20 mg FSH + 625 mcg PGF2α ….. 
9 am 20 mg FSH + 625 mcg PGF2α + 
CIDR™-removal 
….. 
10 pm AI Peak Estradiol 
11 am 150 mcg GnRH + AI Peak Estradiol 
17 am Embryo Recovery + 625 mcg 
PGF2α (post-flush) 
Progesterone + 
U/S 
34 am Repeat d0 Protocol (Except pour-
on treatments)  
Basal Estradiol 
51 am Embryo Recovery + PGF2α (post-
flush) 
Progesterone + 
U/S 
 
Data was analyzed using SAS 9.3 (SAS Institute Inc., 
Cary, NC) for a 2 x 2 factorial arrangement.  Binary data 
were analyzed using the GLIMMIX procedure of SAS, 
while remaining, continuous reproductive and embryo 
parameters were analyzed using the MIXED procedure of 
SAS. The final model included the main effects of treatment 
and period (flush) and the appropriate interaction. Heifer per 
flush was the experimental unit and statistical significance 
was acknowledged at P ≤ 0.05, and 0.05 < P ≤ 0.10 was 
considered a tendency approaching significance. 
 
Results and Discussion 
Embryo quality 
Total embryos recovered did not differ due to treatment 
(P = 0.30), but did decrease in flush 2 compared to flush 1 
(P = 0.02). In addition, there was a treatment x flush 
interaction for total embryos recovered (P = 0.02; Table 1, 
as CON heifers had more embryos recovered in first flush 
and reduced embryos in the second flush compared to PYR 
heifers (Table 1). Embryo quality grades and flush success 
did not differ due to treatment (P ≥ 0.16). However, CON 
heifers had an increase in unfertilized oocytes compared to 
PYR heifers (P ≤ 0.05). Irrespective of treatment, quality 
grade 1 embryos and transferable quality embryos (TQE) 
decreased in flush two compared to flush one (P ≤ 0.05). In 
addition, total unfertilized oocytes was greater in CON 
heifers than PYR heifers (P = 0.04). Due to greater 
unfertilized oocytes in CON heifers there was a subsequent 
treatment x flush interaction for quality Grade 4 embryos (P 
≤ 0.02).  
Hormone analysis 
Progesterone (P4) concentrations on the days of embryo 
collection were not different between treatments; however, 
PYR heifers had a weak decreasing trend in total P4 
concentration (P = 0.15) and a tendency for reduced P4 per 
corpus luteum (P = 0.06; Table 2). Estradiol concentration 
per ovulated follicle (CL) and per total ovarian structure 
(CL and unovulated follicles), as determined by ultrasound 
at embryo recovery, was greater in flush two than flush one 
(P ≤ 0.02, P ≤ 0.03; respectively) but did not differ due to 
treatment (P ≥ 0.23). 
In conclusion, these data indicate that a single use of 
topical 5% permethrin at label dose in superovulated heifers 
resulted in a weak tendency for reduced progesterone 
concentrations, but not to a degree that impacts embryo 
production or quality. Permethrin exposure did not elicit any 
reproductive toxicity on folliculogenesis or maturation. 
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Table 1.  Embryo flushing characteristics for super-stimulated yearling beef heifers after  
treatment with a pyrethroid pour-on 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 CON = Saline Control; PYR= UltraBoss® at labeled recommendation, F1 = First embryo flushing 
(17 days after initial treatment), F2 = Second embryo flushing (51 days after initial treatment). 
2 P-values of main effects of treatment and flush and the treatment x flush interaction (P≤ 0.05; 
considered statistically significant). 
3 Average numbers of embryos graded by International Embryo Transfer Society (IETS) guidelines: 1 
= Excellent or good, 2 = Fair, 3 = poor, 4 = dead or degenerate. 
4 Percentage of total embryos by quality grades. 
5 Transferable quality embryos: embryos that are of satisfactory quality to freeze and transfer. TQE = 
Grade 1 and Grade 2. 
6 Non-viable or dead embryos. 
7 Unfertilized oocytes. 
8 Percentage of animals that had ≥ 5 TQE (average of industry standards). 
 
 
 
 
 
 
 
 
 
 
 Treatment1     
 CON PYR  P-Value2 
Item F1 F2 F1 F2 SEM2 TRT Flush TxF 
Total Embryos 17.0 7.75 9.8 9.8 1.88 0.30 0.02 0.02 
         
Embryo Quality 
Grade3(%)4 
        
     1  4.0 
(29.5) 
2.25 
(33.8) 
5.4 
(59.3) 
3.0 
(38.0) 
0.83 
(0.12) 
0.32 
(0.24) 
0.04 
(0.15) 
0.83 
(0.18) 
     2 1.4 
(12.5) 
0.5 
(5.8) 
2.2 
(17.3) 
1.2 
(15.4) 
0.59 
(0.05) 
0.38 
(0.33) 
0.27 
(0.56) 
0.95 
(0.74) 
          TQE5 5.4 
(42.0) 
2.75 
(39.7) 
7.6 
(76.5) 
4.2 
(53.5) 
1.32 
(0.14) 
0.30 
(0.19) 
0.05 
(0.08) 
0.91 
(0.45) 
     3 1.6 
(7.3) 
0.75 
(11.3) 
0.4 
(4.0) 
0.8 
(6.3) 
0.37 
(0.02) 
0.29 
(0.22) 
0.67 
(0.34) 
0.26 
(0.80) 
     4 10.0 
(50.8) 
4.25 
(49.0) 
1.6 
(17.5) 
4.8 
(40.2) 
2.12 
(0.12) 
0.16 
(0.20) 
0.67 
(0.14) 
0.02 
(0.29) 
          Degenerate6 3.2 
(16.7) 
1.0 
(11.7) 
1.2 
(13.5) 
4.2 
(34.2) 
1.09 
(0.70) 
0.72 
(0.35) 
0.76 
(0.42) 
0.10 
(0.21) 
          UFO7 6.8 
(34.1) 
3.0 
(33.8) 
0.4 
(4.0) 
0.6 
(6.0) 
1.40 
(0.08) 
0.04 
(0.02) 
0.14 
(0.71) 
0.10 
(0.95) 
         
Flush Sucess8 0.80 0.25 0.80 0.60 1.08 0.50 0.13 0.50 
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Table 2.  Hormonal, ultrasound, and embryo flushing characteristics for super-stimulated yearling beef heifers 
after treatment with a pyrethroid pour-on 
1 CON = Saline Control; PYR= UltraBoss® at labeled recommendation, F1 = First embryo flushing (17 days 
after initial treatment), F2 = Second embryo flushing (51 days after initial treatment). 
2 P-values of main effects of treatment and flush and the treatment x flush interaction (P ≤ 0.05; considered 
statistically significant). 
3 Counted corpus lutea (CL) and unovulated structures from both ovaries via rectal ultrasound at embryo recovery. 
4 Counted corpus lutea (CL) from both ovaries via rectal ultrasound at embryo recovery. 
5 Counted unovulated structures from both ovaries via rectal ultrasound at embryo recovery. 
6 Taken at embryo recovery by venipuncture of caudal tail vein. 
7 Taken prior to initiation of CIDR protocol by venipuncture of caudal tail vein. 
8 Taken during standing estrus or at timed artificial insemination (TAI) by venipuncture of caudal tail vein. 
9 Number of total embryos divided by total number of corpus lutea (CL). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Treatment1     
 CON PYR  P-Value2 
Item F1 F2 F1 F2 SEM2 TRT Flush TxF 
Total Structures3 19.4 15.2 15.2 15.2 3.95 0.59 0.17 0.17 
CL Total4 18.0 12.8 13.8 12.8 2.47 0.56 0.12 0.27 
Unovulated Total5 1.4 2.4 1.4 2.4 0.58 1.00 0.21 1.00 
Progesterone (ng/ml)6 94.03 82.94 42.19 32.00 22.63 0.15 0.31 0.96 
P4/CL Ratio 4.94 4.98 2.86 2.48 0.74 0.06 0.76 0.70 
Resting Estradiol (pg/ml)7 2.71 2.02 1.71 2.23 0.21 0.21 0.79 0.07 
Peak Estradiol (pg/ml)8 42.83 50.58 25.52 47.57 6.93 0.33 0.15 0.47 
Estradiol/CL Ratio 2.41 5.07 1.88 3.66 0.57 0.26 0.02 0.60 
Estradiol/Total Structure Ratio 2.22 3.94 1.70 2.96 0.41 0.23 0.03 0.71 
Recovery Rate9 96.0 89.0 74.0 77.0 0.12 0.35 0.87 0.69 
